Works matching IS 01495992 AND DT 2017 AND VI 40 AND IP 6

Results: 26

In This Issue of .

Published in:

2017

By:

Bingham, Max

Publication type:

Editorial

Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators.

Published in:

2017

By:

Svensson, Elisabeth;
Baggesen, Lisbeth M.;
Johnsen, Søren P.;
Pedersen, Lars;
Nørrelund, Helene;
Buhl, Esben S.;
Haase, Christiane L.;
Thomsen, Reimar W.

Publication type:

journal article

Predicting and Reducing Driving Mishaps Among Drivers With Type 1 Diabetes.

Published in:

2017

By:

Cox, Daniel J.;
Gonder-Frederick, Linda A.;
Singh, Harsimran;
Ingersoll, Karen S.;
Banton, Tom;
Grabman, Jesse H.;
Schmidt, Karen;
Clarke, William

Publication type:

journal article

The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.

Published in:

2017

By:

Polonsky, William H.;
Hessler, Danielle;
Ruedy, Katrina J.;
Beck, Roy W.;
DIAMOND Study Group

Publication type:

journal article

Response to Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2. Diabetes Care 2016;39:924-933.

Published in:

2017

By:

Cummings, David E.;
Cohen, Ricardo V.

Publication type:

Letter

Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2. Diabetes Care 2016;39:924-933.

Published in:

2017

By:

Halpern, Bruno;
Cercato, Cintia;
Mancini, Marcio Correa

Publication type:

Letter

Improvement of Glucose Control and Reduction of Hypoglycemia Following Intravenous Immune Globulins in a Child With Type 1 Diabetes and High Levels of Insulin Antibodies.

Published in:

2017

By:

Marchand, Lucien;
Luigi, Perrine;
Place, Jerome;
Dalla-Vale, Fabienne;
Farret, Anne;
Renard, Eric

Publication type:

Letter

Insulin-Induced Distant Site Lipoatrophy.

Published in:

2017

By:

Aki Kondo;
Akinobu Nakamura;
Jun Takeuchi;
Hideaki Miyoshi;
Tatsuya Atsumi;
Kondo, Aki;
Nakamura, Akinobu;
Takeuchi, Jun;
Miyoshi, Hideaki;
Atsumi, Tatsuya

Publication type:

Letter

Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.

Published in:

2017

By:

Misaghian-Xanthos, Negin;
Shariff, Afreen I.;
Mekala, Kavya;
Fearrington, Loretta R.;
Setji, Tracy L.;
Aloi, Joseph A.;
Buse, John B.

Publication type:

Letter

Mary Tyler Moore (1936-2017): Diabetes Educator and Advocate.

Published in:

2017

By:

Atkinson, Mark A.;
Nierras, Concepcion R.

Publication type:

journal article

Diabetes Prevention Program in Youth (Insulin Superheroes Club) Pilot: Improvement in Metabolic Parameters and Physical Fitness After 16 Weeks of Lifestyle Intervention.

Published in:

2017

By:

Mantilla, Chantis;
Jones, Tamekia;
Decker, Kristina M.;
Jacobo, Andrea M.;
Sontheimer, Sylvia Y.;
Mirro, Margaret R.;
Hare, Marion E.;
Han, Joan C.

Publication type:

Letter

Issues and Events.

Published in:: 2017
Publication type:: journal article

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.

Published in:

2017

By:

Kazda, Christof M;
Ding, Ying;
Kelly, Ronan P;
Garhyan, Parag;
Shi, Chunxue;
Lim, Chay Ngee;
Fu, Haoda;
Watson, David E;
Lewin, Andrew J;
Landschulz, William H;
Deeg, Mark A;
Moller, David E;
Hardy, Thomas A

Publication type:

journal article

A Special Thanks to the Reviewers of .

Published in:: 2017
Publication type:: Editorial

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.

Published in:

2017

By:

Soliman, Elsayed Z.;
Backlund, Jye-Yu C.;
Bebu, Ionut;
Orchard, Trevor J.;
Zinman, Bernard;
Lachin, John M.;
DCCT/EDIC Research Group

Publication type:

journal article

Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.

Published in:

2017

By:

Bidadkosh, Arash;
Lambooy, Sebastiaan P. H.;
Heerspink, Hiddo J.;
Pena, Michelle J.;
Henning, Robert H.;
Buikema, Hendrik;
Deelman, Leo E.

Publication type:

journal article

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.

Published in:

2017

By:

Lachin, John M.;
Bebu, Ionut;
Bergenstal, Richard M.;
Pop-Busui, Rodica;
Service, F. John;
Zinman, Bernard;
Nathan, David M.;
DCCT/EDIC Research Group

Publication type:

journal article

Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.

Published in:

2017

By:

Ferrannini, Ele;
Baldi, Simona;
Frascerra, Silvia;
Astiarraga, Brenno;
Barsotti, Elisabetta;
Clerico, Aldo;
Muscelli, Elza

Publication type:

journal article

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.

Published in:

2017

By:

Battelino, Tadej;
Nimri, Revital;
Dovc, Klemen;
Phillip, Moshe;
Bratina, Natasa

Publication type:

journal article

The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.

Published in:

2017

By:

Farren, Maria;
Daly, Niamh;
McKeating, Aoife;
Kinsley, Brendan;
Turner, Michael J.;
Daly, Sean

Publication type:

journal article

Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample.

Published in:

2017

By:

Ekblad, Laura L.;
Rinne, Juha O.;
Puukka, Pauli;
Laine, Hanna;
Ahtiluoto, Satu;
Sulkava, Raimo;
Viitanen, Matti;
Jula, Antti

Publication type:

journal article

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.

Published in:

2017

By:

Solomon, Sharon D;
Chew, Emily;
Duh, Elia J;
Sobrin, Lucia;
Sun, Jennifer K;
VanderBeek, Brian L;
Wykoff, Charles C;
Gardner, Thomas W

Publication type:

journal article

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980

Published in:

2017

By:

Aroda, Vanita R;
Rosenstock, Julio;
Wysham, Carol;
Unger, Jeffrey;
Bellido, Diego;
González-Gálvez, Guillermo;
Takami, Akane;
Guo, Hailing;
Niemoeller, Elisabeth;
Souhami, Elisabeth;
Bergenstal, Richard M;
LixiLan-L Trial Investigators

Publication type:

journal article

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.

Published in:

2017

By:

Rosenstock, Julio;
Aronson, Ronnie;
Grunberger, George;
Hanefeld, Markolf;
Piatti, PierMarco;
Serusclat, Pierre;
Cheng, Xi;
Zhou, Tianyue;
Niemoeller, Elisabeth;
Souhami, Elisabeth;
Davies, Melanie;
LixiLan-O Trial Investigators

Publication type:

journal article

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139-148.

Published in:

2017

By:

Mita, Tomoya;
Katakami, Naoto;
Yoshii, Hidenori;
Onuma, Tomio;
Kaneto, Hideaki;
Osonoi, Takeshi;
Shiraiwa, Toshihiko;
Kosugi, Keisuke;
Umayahara, Yutaka;
Yamamoto, Tsunehiko;
Yokoyama, Hiroki;
Kuribayashi, Nobuichi;
Jinnouchi, Hideaki;
Gosho, Masahiko;
Shimomura, Iichiro;
Watada, Hirotaka;
Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial

Publication type:

journal article

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.

Published in:

2017

By:

Mita, Tomoya;
Katakami, Naoto;
Shiraiwa, Toshihiko;
Yoshii, Hidenori;
Onuma, Tomio;
Kuribayashi, Nobuichi;
Osonoi, Takeshi;
Kaneto, Hideaki;
Kosugi, Keisuke;
Umayahara, Yutaka;
Yamamoto, Tsunehiko;
Matsumoto, Kazunari;
Yokoyama, Hiroki;
Tsugawa, Mamiko;
Gosho, Masahiko;
Shimomura, Iichiro;
Watada, Hirotaka;
Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial

Publication type:

journal article

Works matching IS 01495992 AND DT 2017 AND VI 40 AND IP 6

In This Issue of .

Early Glycemic Control and Magnitude of HbA<sub>1c</sub> Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators.

Predicting and Reducing Driving Mishaps Among Drivers With Type 1 Diabetes.

The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.

Response to Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m<sup>2</sup>. Diabetes Care 2016;39:924-933.

Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m<sup>2</sup>. Diabetes Care 2016;39:924-933.

Improvement of Glucose Control and Reduction of Hypoglycemia Following Intravenous Immune Globulins in a Child With Type 1 Diabetes and High Levels of Insulin Antibodies.

Insulin-Induced Distant Site Lipoatrophy.

Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.

Mary Tyler Moore (1936-2017): Diabetes Educator and Advocate.

Diabetes Prevention Program in Youth (Insulin Superheroes Club) Pilot: Improvement in Metabolic Parameters and Physical Fitness After 16 Weeks of Lifestyle Intervention.

Issues and Events.

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.

A Special Thanks to the Reviewers of .

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.

Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.

Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.

The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.

Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample.

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139-148.

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.